Answers are grounded in this paper and cite their sources.
Healthcare professionals face increasing challenges in managing older patients in daily practice, particularly those suffering from multiple comorbid states [1]. Clinical guidelines and recommendations driving routine clinical decisions are primarily generated using evidence from randomized controlled trials that investigate the effects of specific drugs for the treatment of individual diseases [2]. However, the clinical complexity of older multimorbid patients typically prevents them from meeting the stringent inclusion and exclusion criteria of randomized controlled trials [3,4]. As a consequence, there is a concerning lack of robust, real-world evidence for treating this highly heterogenous population safely and effectively also given the ever-increasing number of marketed drugs [5]. Additionally, traditional disease management typically follows a single disease approach to care that is not adapted to the needs of persons with multimorbidity where the potential for inappropriate polypharmacy, medication interactions, and unwanted effects is greatly increased [6].
No takes yet. Share an insight, caveat, or question.
Arduino A. Mangoni (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: